For the 4th Consecutive Survey, Mercy Medical Center Earns National Cancer Accreditation
Mercy Medical Center, a member of Catholic Health Services (CHS), has earned a Commission on Cancer (CoC) Three-Year Accreditation with Gold-Level Commendation to its cancer program. The CoC is a quality program of the American College of Surgeons. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care.
This is the fourth consecutive survey that Mercy has earned this recognition and has received perfect scores. Other CoC accredited CHS facilities include St. Francis Hospital, Good Samaritan Hospital Medical Center and St. Charles Hospital.
“Approval by the Commission on Cancer is given only to those facilities that have voluntarily committed to provide the best diagnosis and treatment of cancer,” said CHS’s Chair of Cancer Services Bhoomi Mehrotra, M.D. “This achievement is held by some of the top cancer institutions across the country and Mercy is extremely deserving of this recognition.”
As a CoC-accredited cancer center, Mercy takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists and other cancer specialists. This partnership results in improved patient care through various cancer-related programs including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease and end-of-life care.
When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling and patient centered services including psycho-social support, a patient navigation process and a survivorship care plan. And, like all CoC-accredited facilities, Mercy maintains a cancer registry that contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society. This database explores trends in cancer care.
“I am extremely proud of our team for this accomplishment and thankful to CHS for continuing to expand and offer quality cancer care on Long Island,” said Peter Scaminaci, president at Mercy. “We choose to pursue CoC accreditation because it provides a framework that aligns with our goals of continuing to provide quality, all inclusive, advanced, personalized care to our patients and their families.”
Cancer care at Mercy continues to expand. In early January 2020, CHS opened a 12,350-square-foot CHS Cancer Institute at Mercy. The CHS Cancer Institute provides patients and their families with a one-stop, multidisciplinary approach to cancer. It features a 15-bay infusion center, 5 physician offices and 10 exam rooms, with flexible space that can be converted to accommodate for additional growth and services. Patients get their diagnostic images at the same time and place as they come to consult with as many as three oncologists in one visit: a medical oncologist/hematologist, a surgical oncologist and a radiation oncologist.
The next CoC survey at Mercy will be conducted in 2022.
For more information about Mercy Medical Center’s cancer services visit https://mercymedicalcenter.chsli.org/chs-cancer-institute-mercy-medical-center or call 516-626-3729.
For information regarding CHS’s oncology services, visit https://www.chsli.org/oncology.